Institut Du Cancer De Montpellier - Val D'aurelle

This study tested a combination of the targeted drug regorafenib with chemotherapy (mGEMOX) in 66 people with advanced bile duct cancer that could not be removed by surgery. The main goal was to find the safest dose and check for side effects. This is not a cure, but aims to cont…

This study tested whether adding sorafenib to irinotecan helps control advanced colorectal cancer with a KRAS mutation. It involved 173 adults whose cancer had worsened after all standard treatments. The goal was to see if the combination slowed tumor growth better than either dr…

This study tested a combination of two drugs, sorafenib and irinotecan, in 64 adults with advanced colorectal cancer that had a specific gene change called K-RAS. The goal was to see if the combination could control the cancer after other treatments had stopped working. The study…

This study tested a combination of three drugs (gemcitabine, trastuzumab, and erlotinib) as a first treatment for people with metastatic pancreatic cancer that has spread. The goal was to see if the combination could control the disease and improve survival. 63 patients took part…

This study tested whether using e-health tools—like a smartphone app or a phone call from a nurse—could help women manage pain and anxiety after a breast biopsy. About 193 women took part. The goal was to see if these tools improved pain control and reduced worry compared to stan…

This study tested whether a yoga program done at home and in group sessions is practical for breast cancer patients on hormone therapy who have joint pain. 24 patients participated, doing daily home yoga and attending 6 sessions with a therapist. The goal was to see if patients w…

This study tested a simple technique combining guided breathing (cardiac coherence) with a hypnosis session to help women feel less anxious before breast or gynecologic cancer surgery. 53 participants were asked to practice breathing exercises for at least 14 sessions in the week…

This study analyzed tumor and blood samples from 160 people with esophageal or rectal cancer to find genetic markers that might predict how well they respond to chemoradiotherapy before surgery. The goal was to better understand why some patients benefit more than others. No new …

This study looked at how people with brain tumors or breast cancer perceive their own memory problems, especially remembering to do future tasks. Researchers compared 426 participants, including healthy individuals, to understand the link between memory complaints, depression, an…

This study looked at whether a simple blood test can predict which patients will have long-term side effects from radiation therapy. Researchers measured how well certain immune cells (CD8 T-cells) die after being exposed to radiation. The goal was to see if this test could help …

This study looked at whether measuring certain proteins in spinal fluid can help detect breast cancer that has spread to the lining of the brain (leptomeningeal metastases). Researchers collected spinal fluid from 51 breast cancer patients suspected of having this spread. The goa…

This study followed 26 adults with low-grade glioma who were receiving chemotherapy (temozolomide) for the first time after surgery. Researchers measured how the treatment affected patients' quality of life, thinking skills, and emotional well-being over one year. The goal was to…